Antoni Wiedlocha funded by the EEA Poland-Norway grants
The proposal "Novel targeted therapy based on dual warhead conjugates against FGFR dependent cancers", with senior scientist Antoni Wiedlocha at Department of Molecular Cell Biology, Institute for Cancer Research, as Norwegian partner and professor Jacek Otlewski at the University of Wroclaw as Polish parther, has been awarded funding from the EEA Poland-Norway grants under the "Applied Research" programme.
Links:
From the National Centre for Research and Development in Poland:
Published in Level 2 journals, first or last author from Oslo University Hospital.
Lyngstad G, Skjelbred P, Swanson DM, Skoglund LA(2024) Correction to: Analgesic effect of oral paracetamol 1000 mg/ibuprofen 400 mg, paracetamol 1000 mg/codeine 60 mg, paracetamol 1000 mg/ibuprofen 400 mg/codeine 60 mg, or placebo on acute postoperative pain: a single‑dose, randomized, and double‑blind study Eur J Clin Pharmacol(in press) DOI 10.1007/s00228-024-03688-4, PubMed 38653785
Bratke H, Biringer E, Ushakova A, Margeirsdottir HD, Kummernes SJ, Njølstad PR, Skrivarhaug T(2024) Ten Years of Improving Glycemic Control in Pediatric Diabetes Care: Data From the Norwegian Childhood Diabetes Registry Diabetes Care(in press) DOI 10.2337/dc24-0086, PubMed 38648259
Beck D, de Lange AG, Gurholt TP, Voldsbekk I, Maximov II, Subramaniapillai S, Schindler L, Hindley G, Leonardsen EH, Rahman Z, van der Meer D, Korbmacher M, Linge J, Leinhard OD, Kalleberg KT, Engvig A, Sønderby I, Andreassen OA, Westlye LT(2024) Dissecting unique and common variance across body and brain health indicators using age prediction Hum Brain Mapp, 45(6), e26685 DOI 10.1002/hbm.26685, PubMed 38647042